Coronavirus Disease (COVID-19) is caused by coronavirus. Coronavirus is a type of virus which causes respiratory illness in humans and can causes serious illness in geriatric population (Mainly those with diabetes, chronic respiratory disease, cardiovascular disease, and cancer). Out of the seven types of coronavirus, SARS-CoV-2 is the one which can cause severe diseases like Middle East respiratory syndrome (MERS) and sudden acute respiratory syndrome (SARS). Increasing outbreak of covid-19 is increasing the demand for coronavirus vaccines, which will result in expansion of coronavirus vaccine market during the forecast period.
Major factors responsible for the growth of this market are fast adoption of advance technologies, growing number of corona patients, increasing healthcare expenditures, rising awareness about corona virus, and increasing efforts by the pharmaceutical companies for the development of covid-19 vaccines. Furthermore, increasing research investments for the R&D of covid-19 vaccines is anticipated to drive the market growth in future. However, high cost required for clinical trials and for validation of vaccines is restraining the growth of coronavirus vaccine market.
The Coronavirus Vaccine Market can be segmented on the basis of Infection Type, Vaccine Type, End-Users, and region. On the basis of Infection Type, the market can be divided into HCoV-229E, HCoV-OC43, SARS-CoV, New Haven CoV, HKU1-CoV, and MERS-CoV. SARS-CoV segment is expected to dominate the market as this virus is the main reason of covid-19 outbreak. On the basis of Vaccine Type, the market can be segmented into Inactivated coronavirus vaccine, Live attenuated coronavirus vaccine, and S-Protein based coronavirus vaccine. In terms of End-Users, market is divided into Hospitals, Clinics, Research Institutes, and Others. On the basis of region, the market is segmented into the North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa. North America is expected to dominate the coronavirus vaccine market in the coming future.
Some of the major key Players of coronavirus vaccine market are I-Mab Biopharma, Medicago, Airway Therapeutics, Tiziana Life Sciences, Inovio Pharmaceuticals, Novavax, Inc, Moderna, AstraZeneca, Pfizer, Johnson &Johnson, GlaxoSmithKline, Bharath Biotech, Serum Institute of India, Sinopharm, AnGes, AIVITABiomedical, CanSinoBio, eubiologics, Genexine, GreenLight Bioscience, Gennova, Heat Biologics, INOVIO, IIBR, medicago, Symvivo, Valneva, Zydus Cadila, and Other Prominent Players.